SEC Form 4 · accession 0001387131-15-003164

Ohr Pharmaceutical Inc · OHRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Nov 2, 2015

Accepted (ET)

Nov 4, 2015 · 1:32 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001173281

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	500	$2.97	A	65,073	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	300	$2.9799	A	65,373	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	400	$2.98	A	65,773	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	750	$2.9897	A	66,523	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	1,800	$2.9899	A	68,323	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	2,600	$2.99	A	70,923	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	700	$2.9997	A	71,623	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	300	$2.9999	A	71,923	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	2,600	$3.00	A	74,523	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	1,300	$3.01	A	75,823	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	200	$3.0197	A	76,023	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	200	$3.02	A	76,223	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	200	$3.0297	A	76,423	D
Common Stock, par value $0.0001 per share	Nov 2, 2015	P	1,400	$3.03	A	77,823	D
Common Stock, par value $0.0001 per share	Nov 3, 2015	P	100	$3.01	A	77,923	D
Common Stock, par value $0.0001 per share	holding	—	—		—	425,505	I	By SKS Ocular, LLC

No Table II lines on this filing.